Arbutus Biopharma Corp

ABUS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001447028

SEC filings (opens in a new tab)

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Arbutus Biopharma Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of ABUS: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	91	1	100	+10
Shares	28.9M	10	34.9M	+5.99M (+20.7%)
Value	$87.6M	$0	$149.8M	+$62.1M (+70.9%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Arbutus Biopharma Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ABUS in Q3 2021
Institution	Shares	Value	% of portfolio
Millennium Management LLC	1,021,695	$4.38M	0.01%
SG Americas Securities, LLC	599,349	$2.57M	0.01%
Woodline Partners LP	496,172	$2.13M	0.04%
Marshall Wace, LLP	397,088	$1.70M	0.01%
Walleye Capital LLC	231,037	$991.0K	0.03%
Marshall Wace North America L.P.	222,739	$955.0K	0.00%
Schonfeld Strategic Advisors LLC	145,800	$626.0K	0.01%
Kerrisdale Advisers, LLC	100,000	$429.0K	0.05%
Pura Vida Investments, LLC	100,000	$429.0K	0.03%
Walleye Trading LLC	76,796	$329.0K	0.01%
Apis Capital Advisors, LLC	70,000	$300.0K	0.29%
Shay Capital LLC	60,000	$257.0K	0.08%
Centiva Capital, LP	57,500	$247.0K	0.02%
Prelude Capital Management, LLC	39,000	$167.0K	0.01%
Belvedere Trading LLC	33,705	$140.0K	0.04%
MetLife Investment Management	30,042	$128.9K	0.00%
Metropolitan Life Insurance Co	22,728	$97.5K	0.00%
ExodusPoint Capital Management, LP	22,184	$95.0K	0.00%
HighTower Advisors, LLC	19,065	$82.0K	0.00%
HRT Financial LP	18,724	$80.0K	0.00%
Parallax Volatility Advisers, L.P.	15,631	$67.0K	0.00%
XTX Topco Ltd	11,604	$50.0K	0.02%
Arkadios Wealth Advisors	1,000	$4.00K	0.00%
Koshinski Asset Management, Inc.	500	$2.15K	0.00%

Sold out (14)

Institutions that held Arbutus Biopharma Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ABUS in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Acadian Asset Management LLC	119,020	$361.0K
Virtu Financial LLC	93,196	$282.0K
Credit Suisse AG	86,771	$262.0K
UBS Group AG	62,310	$189.0K
AQR Capital Management LLC	19,036	$58.0K
Assenagon Asset Management S.A.	17,851	$54.0K
Qube Research & Technologies Ltd	15,474	$47.0K
IHT Wealth Management, LLC	15,000	$45.0K
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors	13,000	$39.0K
Sargent Investment Group, LLC	12,339	$37.0K
Scotia Capital Inc.	11,690	$35.0K
Retirement Group, LLC	500	$2.00K
AdvisorNet Financial, Inc	272	$1.00K
FMR LLC	1	$0

Not filed for Q3 2021 yet (1)

Institutions that held Arbutus Biopharma Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABUS in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
CWM, LLC	10	$0